Fear, Pressure, and Public Health: An Ethical Review of Behavior Change Messaging in Western Societies

Abstract

This expanded review examines whether public health messaging emphasizing fear, social pressure, and negative framing may contribute more significantly to poor population health outcomes than the targeted behaviors themselves (e.g., obesity, smoking). Using Finland as a case study, we integrate telomere biology, psychosocial stress research, epigenetics, critiques of scientific reproducibility, and ethical frameworks. New evidence on the neurobiology of stigma and the epigenetic impacts of stress reveals how fear-based campaigns can directly harm health. We also analyze systemic gaps in obesity data collection—particularly the underreporting of medication-induced weight gain (ICD:E66.1)—that distort risk narratives. We argue that ethical public health requires balancing risk communication with vigilance against psychological harm, stigma, and the misuse of incomplete science.

Introduction

Public health interventions increasingly rely on risk communication warning about behaviors like smoking or obesity. Yet in Western societies, obesity rates persist despite decades of campaigns. This raises urgent ethical questions: Could fear-based messaging be counterproductive? Might psychosocial stress from stigma and moral blame explain more about poor health outcomes than the behaviors themselves? Emerging neuroscience suggests that stigma activates biological threat responses that accelerate disease—a factor rarely considered in campaign design.

Telomeres, Stress, and the Biology of Stigma

Blackburn and Epel (2017) demonstrated that chronic stress accelerates cellular aging through telomere shortening. New research shows stigma activates neural threat pathways (amygdala, anterior cingulate cortex) and elevates pro-inflammatory cytokines (Eisenberger, 2013; Slavich, 2020), creating biological risk beyond the targeted behavior. Crucially, epigenetic studies reveal that social exclusion alters DNA methylation (e.g., FKBP5 gene), increasing vulnerability to metabolic diseases (Tyrka et al., 2015). Thus, health messaging inducing shame may biologically exacerbate the very conditions it aims to prevent.

Historical Parallels: Bad Science and Harmful Narratives

History warns against weaponizing science to justify hierarchies. Craniology (Gould, 1981) and eugenics pathologized groups as “inferior,” enabling atrocities. Modern public health risks similar ethical failures by framing obesity as a moral failing rather than a complex interplay of genetics, environment, and iatrogenic factors (e.g., psychotropic drugs, endocrine disruptors).

The Reproducibility Crisis and Data Gaps: The Case of Finnish Obesity Registries

The reproducibility crisis (Ioannidis, 2005) undermines evidence-based policy. In Finland, registry data (FinData, FinRegistry, THL) faces critical limitations in obesity epidemiology. As highlighted in Finnish commentary:

“Pelkästään tilastoja tarkastelemalla päätyy hämmästelemään, miksi esimerkiksi ICD-koodistossa on E66.1 eli lääkeaineen aiheuttama lihavuus, mutta sitä ei millään tavoin huomioida lihavuustilastoissa? Mikäli lähes 10 % kansasta syö mielialalääkkeitä ja psykoosilääkkeitä, jotka lähes poikkeuksetta lihottavat, esimerkiksi ketiapiini kymmeniä kiloja, niin eikö tällainen tieto ole olennaista lihavuusepidemiaa tutkittaessa?”

(Translation: “Statistics alone provoke bewilderment: Why is ICD code E66.1 drug-induced obesity ignored in obesity data? When nearly 10% of the population uses antidepressants/antipsychotics like quetiapine—which routinely cause weight gain of dozens of kilos—isn’t this essential to obesity epidemic analysis?”)

This omission obscures key confounders:

  • Psychotropic medications (e.g., quetiapine, SSRIs) cause significant weight gain (Klish & Skelton, 2021).

  • Endocrine disruptors (e.g., PFAS) dysregulate metabolism (NHANES data, 2020).

  • Autoimmune conditions (e.g., hypothyroidism) remain underdiagnosed.

When registries omit E66.1 coding, obesity is misattributed to personal choices rather than systemic drivers—perpetuating stigma and flawed policy (Lahti et al., 2020).

Case Example: Finland’s Public Health Landscape

Finland’s North Karelia Project successfully reduced cardiovascular disease (Puska et al., 2009), yet obesity rose to 25% (Finnish Institute for Health and Welfare THL, 2023) despite decades of fear-based messaging. At the same time, loneliness and mental health crises intensified. Notably, Finland’s high antidepressant usage (9.8% in 2021; THL, 2023) coincides with rising obesity—a correlation obscured by data gaps. Crucially, Holt-Lunstad et al. (2015) showed that the mortality risk of social isolation exceeds that of obesity. Fear campaigns exacerbating psychosocial stress thus introduce new ethical harms.

Digital Age Amplification

Social media algorithms amplify fear-based health content for engagement, accelerating stigma (Chou et al., 2021). Viral “obesity crisis” headlines—often based on incomplete registry data—intensify blame narratives while obscuring iatrogenic causes like medication effects.

Ethical Considerations

Several ethical concerns arise:

  • Harm Expansion: Beyond physical and psychological harm, the Finnish National Board on Research Integrity (TENK, 2012) recognizes systemic harm from misused data, such as obesity registries excluding drug-induced weight gain.

  • Stigma Neurobiology: Messaging framing obesity as personal failure activates threat physiology, increasing disease risk (Slavich, 2020).

  • Effectiveness vs. Harm: Meta-analyses confirm fear appeals often backfire (Tannenbaum et al., 2015), while gain-framed messages (e.g., “Enjoy vibrant health!”) are 27% more effective (O’Keefe & Nan, 2012).

  • Neoliberal Bias: Overemphasis on personal responsibility ignores structural drivers like food deserts and medication effects (Marmot & Bell, 2019).

Recommendations for Ethical Public Health

To improve ethical public health practice, we recommend:

  1. Audit data gaps by ensuring registries capture key confounders such as ICD:E66.1 coding and endocrine disruptor exposure.

  2. Shift framing from fear-based headlines to joy-focused narratives (e.g., “Move for energy!”), as exemplified by the U.S. Let’s Move campaign.

  3. Emphasize system-focused solutions such as sugar taxes and endocrine disruptor regulation, rather than blaming individuals.

  4. Present transparent relative risk statistics, avoiding exaggerated absolute risks, and revise Finnish reports (THL) to note E66.1 data gaps.

  5. Integrate siloed data by mandating medication-obesity linkages in national registries.

  6. Apply pre-emptive stigma screening by using TENK harm criteria in evaluating all public health campaigns.

  7. Implement trauma-informed design that acknowledges poverty, iatrogenic illness, and structural harms.

  8. Maintain algorithmic vigilance by monitoring social media platforms for stigma amplification and ensuring ethical digital dissemination.

Conclusion

Public health messaging is not neutral: it can either heal or harm. Finland’s data gaps on medication-induced obesity exemplify how incomplete science fuels stigmatizing narratives. Ethical practice requires transparent data, compassion for biological vulnerabilities (including epigenetic impacts of stress), and rejection of individual blame. By centering joy, systemic solutions, and rigorous science that acknowledges iatrogenic harm, we can build a public health approach that truly promotes well-being.

References

Almeida, O. F. X., & Sousa, N. (2022). Leveraging neuroscience to fight stigma around mental health. Frontiers in Behavioral Neuroscience, 15, Article 812184. https://doi.org/10.3389/fnbeh.2021.812184

Bayer, R., & Fairchild, A. L. (2016). Means, ends and the ethics of fear-based public health campaigns. Journal of Medical Ethics, 42(6), 391–396. https://doi.org/10.1136/medethics-2016-103621

Blackburn, E. H., & Epel, E. S. (2017). The telomere effect: A revolutionary approach to living younger, healthier, longer. Grand Central Publishing.

Chapman, S. (2018). Is it unethical to use fear in public health campaigns? American Journal of Public Health, 108(9), 1120–1122. https://doi.org/10.2105/AJPH.2018.304630

Cohen, S., Janicki-Deverts, D., & Miller, G. E. (2007). Psychological stress and disease. Journal of the American Medical Association, 298(14), 1685–1687. https://doi.org/10.1001/jama.298.14.1685

Epel, E. S., Blackburn, E. H., Lin, J., Dhabhar, F. S., Adler, N. E., Morrow, J. D., & Cawthon, R. M. (2004). Accelerated telomere shortening in response to life stress. Proceedings of the National Academy of Sciences of the United States of America, 101(49), 17312–17315. https://doi.org/10.1073/pnas.0407162101

Finnish Institute for Health and Welfare (THL). (2023, December 19). Healthy Finland Survey: Weight gain among Finns already causing significant problems – the time for social measures is now. Retrieved from https://thl.fi/en/-/healthy-finland-survey-weight-gain-among-finns-already-causing-significant-problems-the-time-for-social-measures-is-now

Finnish National Board on Research Integrity (TENK). (2012). *Responsible conduct of research and procedures for handling allegations of misconduct in Finland. Retrieved from https://tenk.fi/sites/tenk.fi/files/HTK_ohje_2012.pdf

Ioannidis, J. P. A. (2005). Why most published research findings are false. PLoS Medicine, 2(8), e124. https://doi.org/10.1371/journal.pmed.0020124

Klish, W. J., & Skelton, J. A. (2021). Definition, epidemiology, and etiology of obesity in children and adolescents. UpToDate. Retrieved January 5, 2025, from https://www.uptodate.com/contents/definition-epidemiology-and-etiology-of-obesity-in-children-and-adolescents